CoChat

Fatty Acid Consumption and Metabolic Syndrome Components: The GOCADAN Study

Ebbesson, Sven O. E., Tejero, M. Elizabeth, Nobmann, Elizabeth D., Lopez‐Alvarenga, Juan Carlos, Ebbesson, Lars, Romenesko, Terri, Carter, Elizabeth A., Resnick, Helaine E., Devereux, Richard B., MacCluer, Jean W., Dyke, Bennett, Laston, Sandra L., Wenger, Charlotte R., Fabsitz, Richard R., Comuzzie, Anthony G., Howard, Barbara V. · 2007 · Journal of the CardioMetabolic Syndrome
Cited by 64

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Fatty acids (FAs) have been related to changes in glucose and lipid metabolism. In this article, the authors assess the association between intake of specific FAs and components of the metabolic syndrome (MS) in adult Eskimos. A total of 691 Inupiat Eskimos (325 men and 366 women), aged 34 to 75 years, were examined as part of the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study. The investigation included a physical examination, blood pressure measurements, blood sampling under fasting conditions, 2‐hour oral glucose tolerance test, and a personal interview including a validated food frequency questionnaire. Components of MS were defined according to the Third Report of the National Cholesterol Education Program Adult Treatment Panel criteria. Consumption of individual FAs showed associations with MS components. Long‐chain omega‐3 FAs, from fish and sea mammals, were associated with lower blood pressure, serum triglycerides, and 2‐hour glucose and higher high‐density lipoprotein cholesterol, fasting insulin, and homeostasis model assessment. Saturated fat consumption was associated with higher triglyceride levels and blood pressure. Trans‐FA consumption was associated with higher blood pressure. Consumption of long‐chain omega‐3 FAs from marine sources may improve certain MS components, and thus may reduce risk for cardiovascular disease. High consumption of saturated FAs and trans‐FAs may have an adverse effect on MS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1559-4564.2007.07393.x

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 64

Metadata

Authors
Ebbesson, S. O. E., Tejero, M. E., Nobmann, E. D., Lopez‐Alvarenga, J. C., Ebbesson, L., Romenesko, T., Carter, E. A., Resnick, H. E., Devereux, R. B., MacCluer, J. W., Dyke, B., Laston, S. L., Wenger, C. R., Fabsitz, R. R., Comuzzie, A. G., & Howard, B. V.
Venue
Journal of the CardioMetabolic Syndrome
Publisher
Wiley
Published
2007-09
Volume
2
Issue
4
Pages
244-249
ISSN
  • 1559-4564 (ISSN-L)
  • 1559-4572
OpenAlex
W1988017253
Cited by
64
References
6
FWCI
4.84
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Fatty Acid Consumption and Metabolic Syndrome Components: The GOCADAN Study. https://app.cochat.ai/papers/10.1111/j.1559-4564.2007.07393.x
The paper
Ebbesson, S. O. E., Tejero, M. E., Nobmann, E. D., Lopez‐Alvarenga, J. C., Ebbesson, L., Romenesko, T., Carter, E. A., Resnick, H. E., Devereux, R. B., MacCluer, J. W., Dyke, B., Laston, S. L., Wenger, C. R., Fabsitz, R. R., Comuzzie, A. G., & Howard, B. V. (2007). Fatty Acid Consumption and Metabolic Syndrome Components: The GOCADAN Study. Journal of the CardioMetabolic Syndrome. https://doi.org/10.1111/j.1559-4564.2007.07393.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.